Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 7,609,000 $ 2,482,000
Accounts receivable 8,287,000 6,134,000
Prepaid expense and other current assets 862,000 1,381,000
Total current assets 16,758,000 9,997,000
Property and Equipment, net 70,000 147,000
Intangible and Other Assets, net 6,636,000 20,066,000
Goodwill 1,864,000 0
Total assets 25,328,000 30,210,000
Current Liabilities    
Accounts payable and accrued expenses 10,420,000 6,697,000
Accrued contingent consideration 1,812,000 3,206,000
Contract liabilities 339,000 111,000
Secured loan – SLR Facility 800,000 0
Convertible note payable and accrued interest 0 679,000
Total current liabilities 13,371,000 10,693,000
Accrued contingent consideration – long term 396,000  
Warrant liability 1,571,000  
Deferred taxes 0 313,000
Total liabilities 15,338,000 11,006,000
Commitments and Contingencies  
Stockholders’ Equity    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 23,656 and 10,323 shares issued and outstanding as of December 31, 2023 and 2022, respectively. 0 0
Common stock, par value $0.001 per share; 400,000,000 shares authorized; 4,774,116 and 1,880,299 shares issued and outstanding as of December 31, 2023 and 2022, respectively. 81,000 47,000
Additional paid-in capital 258,923,000 229,900,000
Accumulated deficit (249,014,000) (210,743,000)
Total stockholders’ equity 9,990,000 19,204,000
Total liabilities and stockholders’ equity $ 25,328,000 $ 30,210,000